197 related articles for article (PubMed ID: 21996676)
1. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma.
Shirai YT; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K
Am J Pathol; 2011 Dec; 179(6):2920-30. PubMed ID: 21996676
[TBL] [Abstract][Full Text] [Related]
2. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
[TBL] [Abstract][Full Text] [Related]
3. Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-type gastric carcinoma.
Johansson E; Komuro A; Iwata C; Hagiwara A; Fuse Y; Watanabe A; Morishita Y; Aburatani H; Funa K; Kano MR; Miyazono K
Cancer Sci; 2010 Nov; 101(11):2398-403. PubMed ID: 20718757
[TBL] [Abstract][Full Text] [Related]
4. The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells.
Wu WK; Sung JJ; To KF; Yu L; Li HT; Li ZJ; Chu KM; Yu J; Cho CH
J Cell Physiol; 2010 Apr; 223(1):178-86. PubMed ID: 20054823
[TBL] [Abstract][Full Text] [Related]
5. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
7. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
Miyazaki H; Watabe T; Kitamura T; Miyazono K
Oncogene; 2004 Dec; 23(58):9326-35. PubMed ID: 15531927
[TBL] [Abstract][Full Text] [Related]
8. Activation of the bone morphogenetic protein receptor by H11kinase/Hsp22 promotes cardiac cell growth and survival.
Sui X; Li D; Qiu H; Gaussin V; Depre C
Circ Res; 2009 Apr; 104(7):887-95. PubMed ID: 19246680
[TBL] [Abstract][Full Text] [Related]
9. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitor MG-132 lowers gastric adenocarcinoma TMK1 cell proliferation via bone morphogenetic protein signaling.
Wu WK; Sung JJ; Yu L; Cho CH
Biochem Biophys Res Commun; 2008 Jun; 371(2):209-14. PubMed ID: 18435911
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K
Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
[TBL] [Abstract][Full Text] [Related]
13. BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells.
Wen XZ; Miyake S; Akiyama Y; Yuasa Y
Biochem Biophys Res Commun; 2004 Mar; 316(1):100-6. PubMed ID: 15003517
[TBL] [Abstract][Full Text] [Related]
14. Localization of STRO-1, BMP-2/-3/-7, BMP receptors and phosphorylated Smad-1 during the formation of mouse periodontium.
Kémoun P; Laurencin-Dalicieux S; Rue J; Vaysse F; Roméas A; Arzate H; Conte-Auriol F; Farges JC; Salles JP; Brunel G
Tissue Cell; 2007 Aug; 39(4):257-66. PubMed ID: 17662325
[TBL] [Abstract][Full Text] [Related]
15. Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER
Shee K; Jiang A; Varn FS; Liu S; Traphagen NA; Owens P; Ma CX; Hoog J; Cheng C; Golub TR; Straussman R; Miller TW
FASEB J; 2019 Feb; 33(2):1644-1657. PubMed ID: 30161001
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
[TBL] [Abstract][Full Text] [Related]
17. Endoglin is involved in BMP-2-induced osteogenic differentiation of periodontal ligament cells through a pathway independent of Smad-1/5/8 phosphorylation.
Ishibashi O; Ikegame M; Takizawa F; Yoshizawa T; Moksed MA; Iizawa F; Mera H; Matsuda A; Kawashima H
J Cell Physiol; 2010 Feb; 222(2):465-73. PubMed ID: 19918795
[TBL] [Abstract][Full Text] [Related]
18. Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas.
Klose A; Waerzeggers Y; Monfared P; Vukicevic S; Kaijzel EL; Winkeler A; Wickenhauser C; Löwik CW; Jacobs AH
Neoplasia; 2011 Mar; 13(3):276-85. PubMed ID: 21390190
[TBL] [Abstract][Full Text] [Related]
19. Basal expression of bone morphogenetic protein receptor is reduced in mild asthma.
Kariyawasam HH; Xanthou G; Barkans J; Aizen M; Kay AB; Robinson DS
Am J Respir Crit Care Med; 2008 May; 177(10):1074-81. PubMed ID: 18292470
[TBL] [Abstract][Full Text] [Related]
20. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
Xia Y; Babitt JL; Sidis Y; Chung RT; Lin HY
Blood; 2008 May; 111(10):5195-204. PubMed ID: 18326817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
